An appeals court ruling yesterday that dismissed the conviction of a sales rep who sold a drug for non-FDA approved uses could have major ramifications for pharmaceutical companies, which have paid billions in fines for doing just that. Two out of three judges agreed with Alfred Caronia that his rights to free speech were violated. The government is expected to appeal the case, which could find its way to the Supreme Court.
An appeals court ruling yesterday that dismissed the conviction of a sales rep who sold a drug...
From other sites
Video at CNBC.com (Oct 29, 2015)
Video at CNBC.com (Aug 26, 2015)
Video at CNBC.com (Jul 27, 2015)
at CNBC.com (Jun 1, 2015)
at CNBC.com (May 28, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs